Literature DB >> 32112799

Signal regulators of human naïve pluripotency.

Adeleh Taei1, Paniz Rasooli2, Thomas Braun3, Seyedeh-Nafiseh Hassani4, Hossein Baharvand5.   

Abstract

Pluripotent cells transiently develop during peri-implantation embryogenesis and have the capacity to convert into three embryonic lineages. Two typical states of pluripotency, naïve and primed, can be experimentally induced in vitro. The in vitro naïve state can be stabilized in response to environmental inductive cues via a unique transcriptional regulatory program. However, interference with various signaling pathways creates a spectrum of alternative pluripotent cells that display different functions and molecular expression patterns. Similarly, human naïve pluripotent cells can be placed into two main levels - intermediate and bona fide. Here, we discuss several culture conditions that have been used to establish naïve-associated gene regulatory networks in human pluripotent cells. We also describe different transcriptional patterns in various culture systems that are associated with these two levels of human naïve pluripotency.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human pluripotent stem cells; Naïve pluripotency

Year:  2020        PMID: 32112799     DOI: 10.1016/j.yexcr.2020.111924

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Role of heat shock protein 60 in primed and naïve states of human pluripotent stem cells.

Authors:  Hong Seo Choi; Hyun Min Lee; Min Kyu Kim; Chun Jeih Ryu
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

2.  Temporal activation of LRH-1 and RAR-γ in human pluripotent stem cells induces a functional naïve-like state.

Authors:  Adeleh Taei; Tahereh Kiani; Zeinab Taghizadeh; Sharif Moradi; Azam Samadian; Sepideh Mollamohammadi; Ali Sharifi-Zarchi; Stefan Guenther; Azimeh Akhlaghpour; Behrouz Asgari Abibeiglou; Mostafa Najar-Asl; Razieh Karamzadeh; Keynoosh Khalooghi; Thomas Braun; Seyedeh-Nafiseh Hassani; Hossein Baharvand
Journal:  EMBO Rep       Date:  2020-08-16       Impact factor: 8.807

3.  Chicken Interspecies Chimerism Unveils Human Pluripotency.

Authors:  Azimeh Akhlaghpour; Adeleh Taei; Seyyed Abolghasem Ghadami; Zahra Bahadori; Saeed Yakhkeshi; Sepideh Molamohammadi; Tahereh Kiani; Azam Samadian; Zahra Ghezelayagh; Newsha Haghparast; Keynoosh Khalooghi; Thomas Braun; Hossein Baharvand; Seyedeh-Nafiseh Hassani
Journal:  Stem Cell Reports       Date:  2020-12-23       Impact factor: 7.765

4.  Translational and post-translational control of human naïve versus primed pluripotency.

Authors:  Cheng Chen; Xiaobing Zhang; Yisha Wang; Xinyu Chen; Wenjie Chen; Songsong Dan; Shiqi She; Weiwei Hu; Jie Dai; Jianwen Hu; Qingyi Cao; Qianyu Liu; Yinghua Huang; Baoming Qin; Bo Kang; Ying-Jie Wang
Journal:  iScience       Date:  2021-12-17

5.  TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells.

Authors:  Ludovic Vallier; Daniel Ortmann; Peter J Rugg-Gunn; Anna Osnato; Stephanie Brown; Christel Krueger; Simon Andrews; Amanda J Collier; Shota Nakanoh; Mariana Quiroga Londoño; Brandon T Wesley; Daniele Muraro; A Sophie Brumm; Kathy K Niakan
Journal:  Elife       Date:  2021-08-31       Impact factor: 8.140

6.  Large-scale analysis of imprinting in naive human pluripotent stem cells reveals recurrent aberrations and a potential link to FGF signaling.

Authors:  Gal Keshet; Nissim Benvenisty
Journal:  Stem Cell Reports       Date:  2021-09-30       Impact factor: 7.765

Review 7.  From Mice to Men: Generation of Human Blastocyst-Like Structures In Vitro.

Authors:  Dorian Luijkx; Vinidhra Shankar; Clemens van Blitterswijk; Stefan Giselbrecht; Erik Vrij
Journal:  Front Cell Dev Biol       Date:  2022-03-11

Review 8.  To Be or Not to Be a Germ Cell: The Extragonadal Germ Cell Tumor Paradigm.

Authors:  Massimo De Felici; Francesca Gioia Klinger; Federica Campolo; Carmela Rita Balistreri; Marco Barchi; Susanna Dolci
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.